Last reviewed · How we verify

NCT03617237

Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

Recruiting now Last updated 17 April 2026
What this trial tests

trial testing Retrospective Populations in Cancer in 10,000 participants. Currently enrolling.

Timeline
3 July 2012
Primary endpoint
10 July 2030
18 April 2032

Quick facts

Lead sponsorUniversity of Texas Southwestern Medical Center
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment10,000
Start date3 July 2012
Primary completion10 July 2030
Estimated completion18 April 2032
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Texas Southwestern Medical Center

Who can join

Adults 18 to 99, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Registry database repository for determining clinical outcomes primarily of patients who have received or have been evaluated for radiation treatment in either the definitive or palliative setting for both malignant and benign etiologies. To compare the outcomes with National Cancer Data Base (NCDB) of the American College of Surgeon(ACS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03617237.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing